Background: Proper management of multiple sclerosis (MS) requires feedback from clinical
practice via registries. Objective: To introduce the Czech national multiple sclerosis registry …

Background: In order to assess the value of management strategies in multiple sclerosis
(MS), outcome data have to be combined with cost data. This, in turn, requires that cost data …

Objective To assess whether the introduction of the new diagnostic criteria and disease
modifying therapies (DMTs) is associated with higher cost for treating multiple sclerosis …

Background Standardizing health outcomes is challenging in clinical management, but it
also holds the potential for creating a healthcare system that is both more effective and …

Objective Our objectives were to (1) obtain the prevalence and demography of people with
multiple sclerosis (MS) in a representative Colorado population, and (2) to assess the …

Background: Multiple sclerosis (MS) management has changed over time, but changes in
health care utilization by MS patients remain understudied. We estimated physician services …

Multiple sclerosis (MS) is a chronic inflammatory condition of the central nervous system
determined by a presumed autoimmune process mainly directed against myelin …

Introduction Effective treatments that reduce relapses can diminish the impact on MS costs in
the long-term. This study aims to estimate direct costs of RRMS relapses in Catalonia …

Introduction: To estimate the value of interventions in multiple sclerosis (MS)–where lifetime
costs and outcomes cannot be observed–outcome data have to be combined with costs …

We performed a cross-sectional, bottom-up observational study of resource consumption
and quality of life of patients with multiple sclerosis (MS) in Germany. Six centers …